神经血管缠绕辅助设备的全球市场 - 市场规模(各市场区隔)，占有率，法规和偿付的形势，治疗，预测(～2033年)

本报告提供全球神经血管缠绕辅助设备市场相关调查分析，提供各市场区隔的市场规模，市场趋势，竞争情形，COVID-19影响等资讯。

市场模式的主要的内容如下列。

目前上市的神经血管缠绕辅助设备和不断变化的竞争格局

• 主要的产业趋势考察
• 神经血管缠绕辅助设备市场区隔的年度收益和市场预测(2015年～2033年)
• 单位，平均销售价格，市场金额相关市场层级的资料

世界，地区，国家层级的市场具体考察

• 各地区分类的定性市场具体资讯各国考察与全球趋势
• 神经血管缠绕辅助设备市场SWOT分析
• 神经血管缠绕辅助设备市场竞争动态的考察和趋势

透过取得真正的大局（包括医疗保健系统的概述）来促进对市场的了解。此外，市场准入部分可让您透过有关报销政策和监管环境的资讯更深入地了解市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Stryker Corp
• MicroVention Inc
• Cerenovus
• Medtronic Plc
• Balt SAS
• 其他

Abstract

Neurovascular Coiling Assist Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Neurovascular Coiling Assist Devices market for the year 2020 and beyond. Neurovascular Coiling Assist Devices are used during coiling procedures to help hold coils in place as they are placed inside the aneurysm. Neurovascular Coiling Assist Devices can be coil assist stents or coil assist balloons. Neurovascular coiling assist device usage varies between countries, depending on the complexity of the case, costs and doctor's preference. There is a slightly higher usage of balloons over stents, however, this varies depending on the country. Some countries may opt to use balloons due to the lower cost of the device. The usage split between balloons and stents are expected to change from year to year depending on new technology and lower costs.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Coiling Assist Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neurovascular Coiling Assist Devices market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neurovascular Coiling Assist Devices market.
• Competitive dynamics insights and trends provided for Neurovascular Coiling Assist Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Stryker Corp, MicroVention Inc, Cerenovus, Medtronic Plc, Balt SAS and Others.

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neurovascular Coiling Assist Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Neurovascular Coiling Assist Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Neurovascular Coiling Assist Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Coiling Assist Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neurovascular Coiling Assist Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.